A novel RNA detection technique for point-of-care identification of pathogens

Mekbib Astatke1, Olivia Tiburzi1, Amy Connolly2

  • 1Applied Biological Sciences, The Johns Hopkins University Applied Physics Laboratory, Laurel, United States.

Insights

This study introduces a sensitive and portable diagnostic method by combining Nucleic Acid Sequence Based Amplification (NASBA) with immunoassays. This approach enhances point-of-care infection detection capabilities.

Area of Science:

  • Biotechnology
  • Medical Diagnostics
  • Molecular Biology

Background:

  • Current point-of-care (POC) infection diagnostics face limitations: Polymerase Chain Reaction (PCR) is sensitive but requires complex equipment, while lateral flow immunoassays (IA) are portable but lack sensitivity.
  • Bridging the gap between sensitivity and portability is crucial for effective, timely medical interventions in infectious disease diagnosis.

Purpose of the Study:

  • To develop a novel, portable, and highly sensitive diagnostic technique for point-of-care (POC) applications.
  • To integrate isothermal RNA amplification with immunoassay detection for improved microbial diagnostics.

Main Methods:

  • Nucleic Acid Sequence Based Amplification (NASBA) for isothermal RNA amplification.
  • Development of a sandwich immunoassay format involving hapten-labeled probes and specific antibody recognition of DNA-RNA duplexes.
  • Integration of amplicon capture and detection into a single workflow.

Main Results:

  • Demonstration of a portable technique combining NASBA with IA for sensitive detection.
  • Successful tagging of amplicons and formation of a sandwich complex for signal generation.
  • Potential for automation and high sensitivity in a POC setting.

Conclusions:

  • The integrated NASBA-IA technique offers a promising solution for sensitive and portable infection diagnostics.
  • This approach addresses limitations of existing POC methods, paving the way for advanced automated diagnostic platforms.
  • The developed method has significant potential for improving infectious disease management at the point-of-care.